Evotec SE reports results for the quarter ended in June - Earnings Summary

Evotec SE

14/08/2024 09:11

* Evotec SE  EVTG.DE  reported a quarterly adjusted loss
of 54
cents​​ per share for the quarter ended in June, lower than the
same quarter last year, when the company reported EPS of -8
cents.  The mean expectation of three analysts for the quarter
was for a loss of 10 cents per share. Wall Street expected
results to range from -16 cents to -4 cents per share.
    * Revenue rose 6.6% to $182.12 million from a year ago;
analysts
expected $191.93 million. 
    * Evotec SE's reported EPS for the quarter was a loss of 54
cents​.
    * The company reported a quarterly loss of €94.93 million.
    * Evotec SE shares had fallen by 33.8% this quarter and
lost 72.1%
so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 933.3% in the last three months.​ 
    * In the last 30 days, two analysts negatively revised
earnings
estimates

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 8 "strong buy" or "buy," 3
"hold" and 1 "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Evotec SE is
€15.00 
This summary was machine generated from LSEG data August 14 at
08:11 a.m. UTC. ​All figures in euros unless otherwise stated.
(For questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2024      -0.10          -0.54          Missed
 Mar. 31 2024      -0.08          -0.12          Missed
 Dec. 31 2023      0.03           -0.09          Missed
 Sep. 30 2023      -0.06          -0.22          Missed